Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Peros

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Hepato-Gastroenterology|July 13, 2004
Serum gastrin levels in patients with inflammatory bowel diseaseJohn K Triantafillidis, Dimitrios Tzourmakliotis, George Peros, et al.
International Surgery|January 30, 2007
Fas and WAF1 expression in esophageal squamous cell carcinomasKonstantinos Vlachos, Nikolaos Siafakas, Andreas Karameris, et al.
Human Pathology|June 14, 2011
Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patientsAlessandro Lugli, Tatjana Vlajnic, Olivier Giger, et al.
International Journal of Surgery (London, England)|September 16, 2009
Ultrasound-guided catheterization of the internal jugular vein in oncologic patients; comparison with the classical anatomic landmark technique: a prospective studyKonstantinos Serafimidis, George H Sakorafas, George Konstantoudakis, et al.
World Journal of Gastrointestinal Oncology|August 2, 2019
TYMS/KRAS/BRAF molecular profiling predicts survival following adjuvant chemotherapy in colorectal cancerAnastasios Ntavatzikos, Aris Spathis, Paul Patapis, et al.
Histopathology|August 19, 2010
Systematic assessment of protein phenotypes characterizing high-grade tumour budding in mismatch repair-proficient colorectal cancerEva Karamitopoulou, Alessandro Lugli, Ioannis Panayiotides, et al.
European Journal of Endocrinology|September 23, 2008
Multiple endocrine neoplasia type 2A in two families with the familial medullary thyroid carcinoma associated G533C mutation of the RET proto-oncogeneMelpomeni Peppa, Eleni Boutati, Smaragda Kamakari, et al.
World Journal of Gastroenterology|September 22, 2017
Integrating <i>TYMS</i>, <i>KRAS</i> and <i>BRAF</i> testing in patients with metastatic colorectal cancerAnastasios Ntavatzikos, Aris Spathis, Paul Patapis, et al.
Hepato-Gastroenterology|July 13, 2004
Relation between Helicobacter pylori infection, thyroid hormone levels and cardiovascular risk factors on blood donorsJohn K Triantafillidis, Dimitrios Georgakopoulos, Aristofanis Gikas, et al.
Anticancer Research|May 30, 2008
P53Arg72 homozygosity and its increased incidence in left-sided sporadic colorectal adenocarcinomas, in a Greek-Caucasian populationAnastasios Dakouras, Nikolaos Nikiteas, Emmanuel Papadakis, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Hepato-Gastroenterology|July 13, 2004
Serum gastrin levels in patients with inflammatory bowel diseaseJohn K Triantafillidis, Dimitrios Tzourmakliotis, George Peros, et al.
International Surgery|January 30, 2007
Fas and WAF1 expression in esophageal squamous cell carcinomasKonstantinos Vlachos, Nikolaos Siafakas, Andreas Karameris, et al.
Human Pathology|June 14, 2011
Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patientsAlessandro Lugli, Tatjana Vlajnic, Olivier Giger, et al.
International Journal of Surgery (London, England)|September 16, 2009
Ultrasound-guided catheterization of the internal jugular vein in oncologic patients; comparison with the classical anatomic landmark technique: a prospective studyKonstantinos Serafimidis, George H Sakorafas, George Konstantoudakis, et al.
World Journal of Gastrointestinal Oncology|August 2, 2019
TYMS/KRAS/BRAF molecular profiling predicts survival following adjuvant chemotherapy in colorectal cancerAnastasios Ntavatzikos, Aris Spathis, Paul Patapis, et al.
Histopathology|August 19, 2010
Systematic assessment of protein phenotypes characterizing high-grade tumour budding in mismatch repair-proficient colorectal cancerEva Karamitopoulou, Alessandro Lugli, Ioannis Panayiotides, et al.
European Journal of Endocrinology|September 23, 2008
Multiple endocrine neoplasia type 2A in two families with the familial medullary thyroid carcinoma associated G533C mutation of the RET proto-oncogeneMelpomeni Peppa, Eleni Boutati, Smaragda Kamakari, et al.
World Journal of Gastroenterology|September 22, 2017
Integrating <i>TYMS</i>, <i>KRAS</i> and <i>BRAF</i> testing in patients with metastatic colorectal cancerAnastasios Ntavatzikos, Aris Spathis, Paul Patapis, et al.
Hepato-Gastroenterology|July 13, 2004
Relation between Helicobacter pylori infection, thyroid hormone levels and cardiovascular risk factors on blood donorsJohn K Triantafillidis, Dimitrios Georgakopoulos, Aristofanis Gikas, et al.
Anticancer Research|May 30, 2008
P53Arg72 homozygosity and its increased incidence in left-sided sporadic colorectal adenocarcinomas, in a Greek-Caucasian populationAnastasios Dakouras, Nikolaos Nikiteas, Emmanuel Papadakis, et al.
Pageof 7